Periodic Reporting for period 5 - NetMoDEzyme (Network models for the computational design of proficient enzymes)
Période du rapport: 2022-05-01 au 2022-12-31
We have successfully generated Markov State Models (MSM) for most of the training enzymes (S1), have developed new unprecedented tools based on correlation-based measures and graph theory (S2) that allow, for the first time, the prediction of distal active site mutations that lead to enhanced enzymatic activity (ACS Catal. 2017, 7, 8524; ACS Catal. 2021, 11, 13733), (S3) have performed some experimental validations within the host institution and also via external collaborations for identifying the key parameters for activity, and (S4) have applied the developed methodologies for the design of new enzymes for the synthesis of beta-blocker drugs.
The obtained results have been presented in multiple international and national conferences: plenary lectures at Gordon Research Conference on Biocatalysis 2016, EuChemS 2022, and TheBio2017; invited lectures at 252nd ACS meeting (Washington), 256th ACS meeting (Boston), 262th ACS meeting (Atlanta), Biotransformations 2017, Protein Engineering Canada 2018, 7th EuChemS 2018, Rideal conference (2018), CECAM workshop (Stuttgart 2018), AmineBioCat 2020, Biotrans 2021, IUPAC Canadian Chemistry conference (2021), FEBS practical course (2021), among others.
We have also established some collaboration agreements with two companies for applying the computational pipelines for enzyme design: one NDA signed with the chemical company BASF, one collaboration project with the French company SEQENS for the 2022-2023 period.